Maslinic Acid Enhances Docetaxel Response in Human Docetaxel-Resistant Triple Negative Breast Carcinoma MDA-MB-231 Cells via Regulating MELK-FoxM1-ABCB1 Signaling Cascade
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Maslinic Acid Enhances Docetaxel Response in Human Docetaxel-Resistant Triple Negative Breast Carcinoma MDA-MB-231 Cells via Regulating MELK-FoxM1-ABCB1 Signaling Cascade
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-09
DOI
10.3389/fphar.2020.00835
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization
- (2019) Meisi Yan et al. Cell Death & Disease
- Advances in the systemic treatment of triple-negative breast cancer
- (2018) J.M. Lebert et al. Current Oncology
- Corosolic acid induces cell cycle arrest and cell apoptosis in human retinoblastoma Y-79 cells via disruption of MELK-FoxM1 signaling
- (2018) Ke Wang et al. ONCOLOGY REPORTS
- FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
- (2018) Bowen Yuan et al. Cell Death & Disease
- Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant
- (2017) Marisa Simon et al. PLoS One
- 3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7
- (2017) Sarfaraz Alam et al. Scientific Reports
- Resensitization of Akt Induced Docetaxel Resistance in Breast Cancer by ‘Iturin A’ a Lipopeptide Molecule from Marine Bacteria Bacillus megaterium
- (2017) Goutam Dey et al. Scientific Reports
- FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway
- (2016) Ke Wang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Triterpenes in cancer: significance and their influence
- (2016) Balraj Singh Gill et al. MOLECULAR BIOLOGY REPORTS
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Biology and Management of Patients With Triple-Negative Breast Cancer
- (2016) P. Sharma ONCOLOGIST
- Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose
- (2015) Hirotsugu Kenmotsu et al. CANCER SCIENCE
- Corosolic acid enhances 5-fluorouracil-induced apoptosis against SNU-620 human gastric carcinoma cells by inhibition of mammalian target of rapamycin
- (2015) HYUN SU LEE et al. Molecular Medicine Reports
- Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells
- (2015) YONG YU et al. ONCOLOGY REPORTS
- Corosolic Acid Exhibits Anti-angiogenic and Anti-lymphangiogenic Effects onIn VitroEndothelial Cells and on anIn VivoCT-26 Colon Carcinoma Animal Model
- (2015) Ki Hyun Yoo et al. PHYTOTHERAPY RESEARCH
- Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway
- (2015) Chung-Yu Ku et al. PLoS One
- EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner
- (2015) Sung-Hak Kim et al. Stem Cell Reports
- Abstract 3039: The MELK/FOXM1 axis is a master regulator of proneural to mesenchymal transition (PMT) in glioma stem cells by controlling EZH2 transcriptional activity
- (2015) Kaushal Joshi et al. CANCER RESEARCH
- Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells
- (2014) Harris Wang et al. BMC CANCER
- FOXM1 mediates resistance to docetaxel in gastric cancerviaup-regulating Stathmin
- (2014) Xiaoxiao Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Oleanolic and maslinic acid sensitize soft tissue sarcoma cells to doxorubicin by inhibiting the multidrug resistance protein MRP-1, but not P-glycoprotein
- (2014) Victor Hugo Villar et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives
- (2014) Nisha R. Parikh et al. PHYTOCHEMISTRY REVIEWS
- Inhibitory effects of maslinic acid upon human esophagus, stomach and pancreatic cancer cells
- (2014) Chun-che Lin et al. Journal of Functional Foods
- MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
- (2014) Yubao Wang et al. eLife
- Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer
- (2013) Y. Zhu et al. MOLECULAR CANCER THERAPEUTICS
- MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
- (2013) Kaushal Joshi et al. STEM CELLS
- FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
- (2012) Yun-Yong Park et al. CARCINOGENESIS
- Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells
- (2010) Jing-song Wang et al. MEDICAL ONCOLOGY
- Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway
- (2010) Chenghai Li et al. Molecular Cancer
- Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway
- (2008) Fernando J. Reyes-Zurita et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search